SLC25A26 and cancer: Additionally, studies on CTB have shown that the suppression of extra-mitochondrial methylation by CTB-induced SLC25A26 overexpression can inhibit cancer cell genesis, progression, and proliferation by inhibiting the methylation of the telomerase reverse transcriptase promoter [28].